What's in Xenon Pharmaceuticals Inc.'s pipeline?

Xenon Pharmaceuticals Inc. has 9 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 2 in Phase 2, 6 in Phase 1.

Which companies overlap with Xenon Pharmaceuticals Inc.'s portfolio?

Top competitors by shared drug class: Eisai Inc., Pfizer, Salvat, XenoPort, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/xenon-pharmaceuticals-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Xenon Pharmaceuticals Inc. — Portfolio Competitive Intelligence Brief

Xenon Pharmaceuticals Inc. pipeline: 0 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 2 Phase 2 6 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
XEN1101	XEN1101	phase 3	sodium channel blocker	Nav1.7	Pain

Therapeutic area mix

Pain · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Eisai Inc. · 1 shared drug class
Pfizer · 1 shared drug class
Salvat · 1 shared drug class
XenoPort, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Xenon Pharmaceuticals Inc.:

Cite this brief

Drug Landscape (2026). Xenon Pharmaceuticals Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/xenon-pharmaceuticals-inc. Accessed 2026-05-16.